BIOBV — Biohit Oyj Cashflow Statement
0.000.00%
- €37.69m
- €34.49m
- €15.70m
- 60
- 55
- 33
- 45
Annual cashflow statement for Biohit Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.5 | 0.601 | 1.85 | 2.57 | 2.7 |
| Depreciation | |||||
| Non-Cash Items | -0.013 | 0.719 | 0.199 | 0.085 | 0.4 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.919 | 0.047 | -1.51 | -2.41 | -4.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.444 | 1.85 | 0.902 | 0.586 | -0.7 |
| Capital Expenditures | -0.033 | -0.059 | -0.248 | -0.402 | -0.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.793 | -0.566 | -0.462 | 0.482 | 1.8 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.76 | -0.625 | -0.71 | 0.08 | 1.2 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.266 | -0.186 | -0.199 | -0.23 | -0.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.063 | 1.02 | 0.003 | 0.474 | 0.2 |